BioStem Technologies, Inc.

NASDAQ:BSEM

Biotechnology

Healthcare
$3.07 -6.54%

-$0.21 today

Market cap
$52.14M
Beta
0.26
P/E (TTM)
-1.8
EPS (TTM)
-$1.63
52W Low $2.25High $8.40

Volume 0.09M

Average 0.07M

BSEM Depreciation & Amortization

Non-cash expense that spreads the cost of physical and intangible assets over their useful lives.

BioStem Technologies, Inc.NASDAQ: BSEM

Depreciation & Amortization · Q2 FY2026 · quarter ended Jun 2026

Depreciation & amortization growth accelerates

Q2 FY2026 depreciation & amortization of $689.32K rose 1034.9% year over year, ahead of the +441.2% change in trailing-twelve-month depreciation & amortization. Sequentially, it rose 27.5% from the prior quarter. Over 3 fiscal years it compounded at -3.4% a year.

Context

  • Depreciation & amortization amounted to 0.5% of revenue in FY2025, up 0.4 pp from a year earlier.
  • Depreciation & amortization increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +1034.9% holds above the trailing-twelve-month pace of +441.2%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
$689.32K+27.5% QoQ
Last fiscal yearDec 2025
$219.42K-25.2% YoY
LTMJun 2026
$1.33M+441.2% YoY
Depreciation & Amortization past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+1034.9%——
1 year-25.2%——
3-year CAGR-3.4%——
5-year CAGR——
10-year CAGR——

Depreciation & Amortization history

USD · from the income statement

Latest · FY2025
219.42K USD
Year-over-year change
-25.2%
4-year CAGR
-6.2%

Depreciation & Amortization vs competitors

How BSEM compares with its peers on the latest reported figures

No competitor Depreciation & Amortization figures are available to compare.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue4.34M6.88M16.69M301.83M47.48M
Cost of Revenue1.47M881.75K1.26M13.75M3.26M
Gross Profit2.87M5.99M15.42M287.86M44.22M
Gross Margin66.0%87.2%92.4%95.4%93.1%
Research & Development119.65K123.31K342K1.91M7.09M
Selling, General & Admin4.19M10.21M22.63M254.75M37.82M
Operating Expenses4.47M10.67M23.2M256.66M44.91M
Depreciation & Amortization283.9K243.42K229.02K293.22K219.42K
EBITDA(602K)(6.52M)(7.55M)31.49M(469.73K)
EBITDA Margin-13.9%-94.8%-45.3%10.4%-1.0%
Operating Income(1.61M)(4.68M)(7.78M)31.2M(689.15K)
Operating Margin-37.0%-68.1%-46.6%10.3%-1.5%
Interest Income0000413.85K
Interest Expense525.88K468.15K700.33K587.22K0
Other Income / Expenses193.93K(2.55M)(704.02K)(587.22K)299.5K
Income Before Tax(1.41M)(7.11M)(8.48M)30.61M(389.65K)
Pre-Tax Margin-32.5%-103.5%-50.8%10.1%-0.8%
Income Tax Expense000(1.27M)6.19M
Net Income(1.45M)(7.07M)(8.48M)31.88M(6.58M)
Net Margin-33.3%-102.9%-50.8%10.6%-13.9%
EPS (Basic)(0.12)(0.62)(0.62)1.95(0.39)
EPS (Diluted)(0.12)(0.62)(0.62)1.47(0.39)
Weighted Avg Shares11.69M11.41M13.71M16.37M16.73M
Weighted Avg Shares (Diluted)11.69M11.41M13.71M21.7M16.73M

BioStem Technologies, Inc.

NASDAQ:BSEM

Intrinsic Alpha fair value

Locked

Current Price

$3.07

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.